Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T21:23:01.435Z.
Calculation as of: 2026-10-06T21:23:01.435Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4553d85706fed5bac33927ddb0c45062b9ca990621471d16f8faa1ad8920ffc8
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Market Cap
$159.80M
Operating Cash Flow Yield
N/A
TTM Avg
1.28%
3Y Avg
1.28%
5Y Avg
1.28%
Market Cap
$159.22M
Operating Cash Flow Yield
N/A
TTM Avg
1.16%
3Y Avg
1.36%
5Y Avg
1.36%
Market Cap
$159.14M
Operating Cash Flow Yield
N/A
TTM Avg
0.52%
3Y Avg
0.52%
5Y Avg
7.75%
Market Cap
$162.04M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$156.22M
Operating Cash Flow Yield
N/A
TTM Avg
2.00%
3Y Avg
1.62%
5Y Avg
3.25%
Market Cap
$165.32M
Operating Cash Flow Yield
11.15%
TTM Avg
9.90%
3Y Avg
5.86%
5Y Avg
5.29%
Market Cap
$153.79M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PepGen Inc. (PEPG) | $159.78M | N/A | N/A | N/A | N/A |
| Minerva Neurosciences, Inc. (NERV)vs › | $159.80M | N/A | 1.28% | 1.28% | 1.28% |
| LifeMD, Inc. (LFMDP)vs › | $159.22M | N/A | 1.16% | 1.36% | 1.36% |
| Coherus Oncology, Inc. (CHRS)vs › | $159.14M | N/A | 0.52% | 0.52% | 7.75% |
| Quanterix Corporation (QTRX)vs › | $162.04M | N/A | N/A | N/A | N/A |
| Inogen, Inc. (INGN)vs › | $156.22M | N/A | 2.00% | 1.62% | 3.25% |
| Nkarta, Inc. (NKTX)vs › | $165.27M | N/A | N/A | N/A | N/A |
| OptimizeRx Corp. (OPRX)vs › | $165.32M | 11.15% | 9.90% | 5.86% | 5.29% |
| Neuronetics, Inc. (STIM)vs › | $153.79M | N/A | N/A | N/A | N/A |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $153.58M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
